Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | May 01, 2025 |
| Number of Shares Purchased | 858,714 |
| Highest Price Paid (p) | 390.80 |
| Lowest Price Paid (p) | 374.30 |
| Volume Weighted Average Price (p) | 384.90 |
| Registered Share Capital Post-Transaction | 9,020,131,983 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,016,051,778 |
Material Changes
Following the settlement of the share purchase, the Company's registered share capital remains at 9,020,131,983 ordinary shares, with 4,080,205 held as treasury shares. The number of ordinary shares with voting rights is now 9,016,051,778.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It serves solely as a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased (858,714) and the volume-weighted average price (384.90p) against the Company's broader buyback programme limits.
- Confirm the updated count of voting shares (9,016,051,778) for disclosure threshold calculations under FCA rules.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.